Real-time Estimate
Tradegate
Other stock markets
|
5-day change | 1st Jan Change | ||
191.34 EUR | -0.05% | -3.35% | +37.01% |
Sep. 05 | SAP SE: A matter of interpretation | |
Sep. 03 | German Shares Retreat Amid Lingering Concerns for Eurozone Economy | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 27.55B | 27.34B | 27.84B | 30.87B | 31.21B | |||||
Other Revenues, Total | -1M | - | - | - | - | |||||
Total Revenues | 27.55B | 27.34B | 27.84B | 30.87B | 31.21B | |||||
Cost of Goods Sold, Total | 8.36B | 7.88B | 7.72B | 8.7B | 8.6B | |||||
Gross Profit | 19.2B | 19.45B | 20.12B | 22.17B | 22.6B | |||||
Selling General & Admin Expenses, Total | 9.32B | 8.46B | 9.55B | 10.58B | 9.77B | |||||
R&D Expenses | 4.29B | 4.45B | 5.18B | 6.16B | 6.32B | |||||
Other Operating Expenses | -18M | 110M | 34M | 186M | 16M | |||||
Other Operating Expenses, Total | 13.6B | 13.03B | 14.76B | 16.92B | 16.1B | |||||
Operating Income | 5.6B | 6.43B | 5.36B | 5.24B | 6.5B | |||||
Interest Expense, Total | -362M | -255M | -210M | -277M | -639M | |||||
Interest And Investment Income | 75M | 113M | - | - | 376M | |||||
Net Interest Expenses | -287M | -142M | -210M | -277M | -263M | |||||
Currency Exchange Gains (Loss) | -51M | -154M | 49M | -151M | 46M | |||||
Other Non Operating Income (Expenses) | 19M | -122M | -543M | -903M | -82M | |||||
EBT, Excl. Unusual Items | 5.28B | 6.01B | 4.65B | 3.91B | 6.2B | |||||
Restructuring Charges | -1.13B | 3M | -157M | -138M | -215M | |||||
Merger & Related Restructuring Charges | - | - | -622M | -611M | -345M | |||||
Gain (Loss) On Sale Of Investments | 444M | 1.02B | 2.9B | -249M | -145M | |||||
Gain (Loss) On Sale Of Assets | - | 194M | 77M | 175M | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | - | - | - | -155M | |||||
EBT, Incl. Unusual Items | 4.6B | 7.22B | 6.85B | 3.09B | 5.34B | |||||
Income Tax Expense | 1.23B | 1.94B | 1.47B | 1.38B | 1.74B | |||||
Earnings From Continuing Operations | 3.37B | 5.28B | 5.38B | 1.71B | 3.6B | |||||
Earnings Of Discontinued Operations | - | - | - | - | 2.36B | |||||
Net Income to Company | 3.37B | 5.28B | 5.38B | 1.71B | 5.96B | |||||
Minority Interest | -50M | -138M | -121M | 576M | 175M | |||||
Net Income - (IS) | 3.32B | 5.14B | 5.26B | 2.28B | 6.14B | |||||
Net Income to Common Incl Extra Items | 3.32B | 5.14B | 5.26B | 2.28B | 6.14B | |||||
Net Income to Common Excl. Extra Items | 3.32B | 5.14B | 5.26B | 2.28B | 3.78B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.78 | 4.35 | 4.45 | 1.95 | 5.26 | |||||
Basic EPS - Continuing Operations | 2.78 | 4.35 | 4.45 | 1.95 | 3.24 | |||||
Basic Weighted Average Shares Outstanding | 1.19B | 1.18B | 1.18B | 1.17B | 1.17B | |||||
Net EPS - Diluted | 2.78 | 4.35 | 4.45 | 1.94 | 5.2 | |||||
Diluted EPS - Continuing Operations | 2.78 | 4.35 | 4.45 | 1.94 | 3.2 | |||||
Diluted Weighted Average Shares Outstanding | 1.19B | 1.18B | 1.18B | 1.18B | 1.18B | |||||
Normalized Basic EPS | 2.72 | 3.06 | 2.36 | 2.58 | 3.47 | |||||
Normalized Diluted EPS | 2.72 | 3.06 | 2.36 | 2.57 | 3.43 | |||||
Dividend Per Share | 1.58 | 1.85 | 1.95 | 2.05 | 2.2 | |||||
Payout Ratio | 53.9 | 36.23 | 41.51 | 125.44 | 39.01 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 6.71B | 7.56B | 6.47B | 6.41B | 7.33B | |||||
EBITA | 6B | 6.85B | 5.77B | 5.7B | 6.81B | |||||
EBIT | 5.6B | 6.43B | 5.36B | 5.24B | 6.5B | |||||
EBITDAR | - | - | - | - | - | |||||
Total Revenues (As Reported) | 27.55B | 27.34B | 27.84B | 30.87B | 31.21B | |||||
Effective Tax Rate - (Ratio) | 26.67 | 26.84 | 21.48 | 44.72 | 32.59 | |||||
Current Domestic Taxes | 625M | 895M | 608M | 539M | 596M | |||||
Current Foreign Taxes | 1.15B | 1B | 1.36B | 1.2B | 1.36B | |||||
Total Current Taxes | 1.78B | 1.9B | 1.97B | 1.73B | 1.95B | |||||
Deferred Domestic Taxes | -3M | -38M | 109M | 89M | 74M | |||||
Deferred Foreign Taxes | -549M | 80M | -606M | -441M | -285M | |||||
Total Deferred Taxes | -552M | 42M | -497M | -352M | -211M | |||||
Normalized Net Income | 3.25B | 3.62B | 2.79B | 3.02B | 4.05B | |||||
Interest on Long-Term Debt | 55M | - | - | - | - | |||||
Non-Cash Pension Expense | 55M | 93M | 62M | 22M | 57M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 7.69B | 7.11B | 7.14B | 8.52B | 8.42B | |||||
General and Administrative Expenses | 1.63B | 1.36B | 2.41B | 2.06B | 1.35B | |||||
Research And Development Expense From Footnotes | 4.29B | 4.45B | 5.38B | 6.38B | 6.4B | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., COGS (Total) | 384M | 270M | 395M | 419M | 507M | |||||
Stock-Based Comp., R&D Exp. (Total) | 429M | 296M | 513M | 625M | 703M | |||||
Stock-Based Comp., S&M Exp. (Total) | 562M | 360M | 655M | 773M | 834M | |||||
Stock-Based Comp., G&A Exp. (Total) | 461M | 157M | 1.23B | 798M | 175M | |||||
Stock-Based Comp., Other (Total) | - | 1M | 1M | - | 1M | |||||
Total Stock-Based Compensation | 1.84B | 1.08B | 2.79B | 2.62B | 2.22B |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 5.31B | 5.31B | 8.9B | 9.01B | 8.12B | |||||
Short Term Investments | 105M | 1.56B | 2.68B | 689M | 3.16B | |||||
Total Cash And Short Term Investments | 5.42B | 6.87B | 11.58B | 9.7B | 11.28B | |||||
Accounts Receivable, Total | 7.56B | 6.2B | 5.89B | 5.78B | 5.89B | |||||
Other Receivables | 1.08B | 814M | 1.09B | 985M | 1.08B | |||||
Notes Receivable | 97M | 80M | 76M | 101M | 101M | |||||
Total Receivables | 8.74B | 7.09B | 7.05B | 6.87B | 7.07B | |||||
Prepaid Expenses | 427M | 495M | 588M | 828M | 844M | |||||
Other Current Assets, Total | 631M | 616M | 826M | 1.13B | 1.38B | |||||
Total Current Assets | 15.21B | 15.07B | 20.04B | 18.52B | 20.57B | |||||
Net Property Plant And Equipment | 5.46B | 4.94B | 4.9B | 4.79B | 4.11B | |||||
Long-term Investments | 2.04B | 3.2B | 5.97B | 5.29B | 5.1B | |||||
Goodwill | 29.16B | 27.56B | 31.09B | 33.11B | 29.09B | |||||
Other Intangibles, Total | 4.49B | 3.78B | 3.97B | 3.84B | 2.5B | |||||
Accounts Receivable Long-Term | 21M | 34M | 1M | - | 5M | |||||
Loans Receivable Long-Term | 117M | 151M | 107M | 129M | 192M | |||||
Deferred Tax Assets Long-Term | 1.25B | 1.17B | 1.78B | 2.06B | 2.19B | |||||
Deferred Charges Long-Term | 1.44B | 1.69B | 2.33B | 3.02B | 3.15B | |||||
Other Long-Term Assets, Total | 1.03B | 873M | 982M | 1.4B | 1.41B | |||||
Total Assets | 60.22B | 58.47B | 71.17B | 72.16B | 68.34B | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 1.58B | 1.21B | 1.58B | 2.15B | 1.78B | |||||
Accrued Expenses, Total | 4.84B | 4.64B | 5.2B | 4.82B | 5.65B | |||||
Short-term Borrowings | 1.1B | 931M | 931M | 928M | - | |||||
Current Portion of Long-Term Debt | 1.43B | 552M | 2.83B | 3.06B | 1.14B | |||||
Current Portion of Leases | 389M | 380M | 407M | 349M | 294M | |||||
Current Income Taxes Payable | 255M | 414M | 304M | 283M | 266M | |||||
Unearned Revenue Current, Total | 4.27B | 4.15B | 4.43B | 5.31B | 4.98B | |||||
Other Current Liabilities | 601M | 559M | 451M | 564M | 533M | |||||
Total Current Liabilities | 14.46B | 12.84B | 16.14B | 17.45B | 14.64B | |||||
Long-Term Debt | 11.09B | 11.86B | 9.24B | 6.96B | 6.03B | |||||
Long-Term Leases | 1.81B | 1.74B | 1.74B | 1.79B | 1.33B | |||||
Unearned Revenue Non Current | 89M | 36M | 13M | 33M | 33M | |||||
Pension & Other Post Retirement Benefits | - | - | - | - | - | |||||
Deferred Tax Liability Non Current | 82M | 158M | 291M | 241M | 265M | |||||
Other Non Current Liabilities | 1.86B | 1.91B | 2.23B | 2.83B | 2.64B | |||||
Total Liabilities | 29.39B | 28.54B | 29.65B | 29.31B | 24.93B | |||||
Common Stock, Total | 1.23B | 1.23B | 1.23B | 1.23B | 1.23B | |||||
Additional Paid In Capital | 545M | 545M | 1.92B | 3.08B | 1.84B | |||||
Retained Earnings | 28.78B | 32.03B | 37.02B | 36.42B | 42.46B | |||||
Treasury Stock | -1.58B | -3.07B | -3.07B | -4.34B | -4.74B | |||||
Comprehensive Income and Other | 1.77B | -1.01B | 1.76B | 3.8B | 2.37B | |||||
Total Common Equity | 30.75B | 29.72B | 38.85B | 40.19B | 43.16B | |||||
Minority Interest | 76M | 211M | 2.67B | 2.66B | 249M | |||||
Total Equity | 30.82B | 29.93B | 41.52B | 42.85B | 43.41B | |||||
Total Liabilities And Equity | 60.22B | 58.47B | 71.17B | 72.16B | 68.34B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 1.19B | 1.18B | 1.18B | 1.17B | 1.17B | |||||
ECS Total Common Shares Outstanding | 1.19B | 1.18B | 1.18B | 1.17B | 1.17B | |||||
Book Value / Share | 25.76 | 25.19 | 32.94 | 34.43 | 36.97 | |||||
Tangible Book Value | -2.91B | -1.63B | 3.8B | 3.24B | 11.56B | |||||
Tangible Book Value Per Share | -2.44 | -1.38 | 3.22 | 2.78 | 9.91 | |||||
Total Debt | 15.82B | 15.46B | 15.15B | 13.08B | 8.79B | |||||
Net Debt | 10.4B | 8.6B | 3.57B | 3.39B | -2.49B | |||||
Debt Equivalent of Unfunded Proj. Benefit Obligation | 230M | 241M | 225M | 114M | 169M | |||||
Debt Equivalent Oper. Leases | - | - | - | - | - | |||||
Minority Interest, Total (Incl. Fin. Div) | 76M | 211M | 2.67B | 2.66B | 249M | |||||
Equity Method Investments, Total | 16M | 14M | 155M | 151M | 135M | |||||
Account Code - Inventory Valuation | 3 | 3 | 3 | 3 | 3 | |||||
Full Time Employees | 100K | 102K | 107K | 112K | 108K | |||||
Order Backlog | 35.5B | 7.15B | 9.45B | 12.03B | 13.74B |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 3.32B | 5.14B | 5.26B | 2.28B | 6.14B | |||||
Depreciation & Amortization - CF | 1.11B | 1.11B | 1.1B | 1.13B | 845M | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 395M | 420M | 412M | 458M | 305M | |||||
Depreciation & Amortization, Total | 1.51B | 1.53B | 1.51B | 1.59B | 1.15B | |||||
Amortization of Deferred Charges, Total - (CF) | 365M | 299M | 266M | 308M | 223M | |||||
(Gain) Loss on Sale of Investments - (CF) | -596M | -1.02B | -2.41B | 1.19B | 145M | |||||
Stock-Based Compensation (CF) | 578M | -226M | 1.67B | 1.43B | 1.13B | |||||
Net Cash From Discontinued Operations | - | - | - | - | 122M | |||||
Other Operating Activities, Total | -953M | 800M | -341M | -934M | -2.55B | |||||
Change In Accounts Receivable | -1.47B | 821M | 414M | 149M | -393M | |||||
Change In Accounts Payable | 328M | 293M | 475M | 163M | 633M | |||||
Change in Unearned Revenues | 984M | 128M | 100M | 685M | 443M | |||||
Change in Other Net Operating Assets | -569M | -583M | -717M | -1.22B | -710M | |||||
Cash from Operations | 3.5B | 7.19B | 6.22B | 5.65B | 6.33B | |||||
Capital Expenditure | -817M | -816M | -800M | -874M | -785M | |||||
Sale of Property, Plant, and Equipment | 71M | 88M | 91M | 60M | 99M | |||||
Cash Acquisitions | -6.22B | -662M | -1.14B | -679M | -1.17B | |||||
Divestitures | 61M | 203M | -72M | 289M | - | |||||
Investment in Marketable and Equity Securities, Total | -122M | -1.8B | -1.14B | 1.87B | -2.66B | |||||
Other Investing Activities, Total | 1M | 1M | -1M | 1M | 5.42B | |||||
Cash from Investing | -7.02B | -2.99B | -3.06B | 667M | 906M | |||||
Long-Term Debt Issued, Total | 3.62B | 2.13B | 1.68B | 158M | 13M | |||||
Total Debt Issued | 3.62B | 2.13B | 1.68B | 158M | 13M | |||||
Long-Term Debt Repaid, Total | -1.71B | -2.81B | -2.33B | -1.87B | -4.41B | |||||
Total Debt Repaid | -1.71B | -2.81B | -2.33B | -1.87B | -4.41B | |||||
Issuance of Common Stock | - | - | - | - | - | |||||
Repurchase of Common Stock | - | -1.49B | - | -1.78B | -949M | |||||
Common Dividends Paid | -1.79B | -1.86B | -2.18B | -2.86B | -2.4B | |||||
Common & Preferred Stock Dividends Paid | -1.79B | -1.86B | -2.18B | -2.86B | -2.4B | |||||
Other Financing Activities, Total | -18M | 35M | 2.77B | 21M | 10M | |||||
Cash from Financing | 102M | -4B | -56M | -6.34B | -7.73B | |||||
Foreign Exchange Rate Adjustments | 110M | -214M | 484M | 134M | -388M | |||||
Miscellaneous Cash Flow Adjustments | - | -1M | -1M | -2M | 0 | |||||
Net Change in Cash | -3.31B | -4M | 3.59B | 109M | -884M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 341M | 244M | 202M | 248M | 393M | |||||
Cash Income Tax Paid (Refund) | 2.33B | 1.19B | 2.06B | 1.68B | 2.16B | |||||
Levered Free Cash Flow | 5.86B | 6.89B | 7.72B | 7.58B | 6.09B | |||||
Unlevered Free Cash Flow | 6.09B | 7.05B | 7.85B | 7.75B | 6.49B | |||||
Change In Net Working Capital | 303M | -933M | -729M | -837M | 380M | |||||
Net Debt Issued / Repaid | 1.91B | -676M | -646M | -1.71B | -4.4B |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.27 | 6.77 | 5.17 | 4.57 | 5.78 | |||||
Return on Total Capital | 8.07 | 8.73 | 6.56 | 5.82 | 7.52 | |||||
Return On Equity % | 11.29 | 17.39 | 15.05 | 4.05 | 8.35 | |||||
Return on Common Equity | 11.15 | 17.02 | 15.33 | 5.78 | 9.06 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 69.68 | 71.16 | 72.26 | 71.8 | 72.43 | |||||
SG&A Margin | 33.83 | 30.95 | 34.29 | 34.28 | 31.3 | |||||
EBITDA Margin % | 24.36 | 27.66 | 23.23 | 20.77 | 23.48 | |||||
EBITA Margin % | 21.77 | 25.05 | 20.72 | 18.47 | 21.81 | |||||
EBIT Margin % | 20.33 | 23.51 | 19.24 | 16.99 | 20.83 | |||||
Income From Continuing Operations Margin % | 12.23 | 19.32 | 19.31 | 5.53 | 11.54 | |||||
Net Income Margin % | 12.05 | 18.82 | 18.88 | 7.4 | 19.67 | |||||
Net Avail. For Common Margin % | 12.05 | 18.82 | 18.88 | 7.4 | 12.1 | |||||
Normalized Net Income Margin | 11.8 | 13.23 | 10.01 | 9.79 | 12.98 | |||||
Levered Free Cash Flow Margin | 21.28 | 25.2 | 27.71 | 24.55 | 19.52 | |||||
Unlevered Free Cash Flow Margin | 22.1 | 25.78 | 28.18 | 25.11 | 20.8 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.49 | 0.46 | 0.43 | 0.43 | 0.44 | |||||
Fixed Assets Turnover | 6.27 | 5.26 | 5.66 | 6.37 | 7.01 | |||||
Receivables Turnover (Average Receivables) | 4.01 | 3.97 | 4.61 | 5.29 | 5.35 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.05 | 1.17 | 1.24 | 1.06 | 1.4 | |||||
Quick Ratio | 0.97 | 1.08 | 1.15 | 0.94 | 1.25 | |||||
Operating Cash Flow to Current Liabilities | 0.24 | 0.56 | 0.39 | 0.32 | 0.43 | |||||
Days Sales Outstanding (Average Receivables) | 91.03 | 92.11 | 79.22 | 68.99 | 68.28 | |||||
Average Days Payable Outstanding | 67.1 | 64.84 | 69.63 | 78.12 | 83.34 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 51.33 | 51.67 | 36.48 | 30.54 | 20.25 | |||||
Total Debt / Total Capital | 33.92 | 34.07 | 26.73 | 23.39 | 16.84 | |||||
LT Debt/Equity | 41.85 | 45.44 | 26.44 | 20.43 | 16.94 | |||||
Long-Term Debt / Total Capital | 27.66 | 29.96 | 19.38 | 15.65 | 14.09 | |||||
Total Liabilities / Total Assets | 48.81 | 48.82 | 41.66 | 40.62 | 36.48 | |||||
EBIT / Interest Expense | 15.48 | 25.2 | 25.51 | 18.93 | 10.17 | |||||
EBITDA / Interest Expense | 19.64 | 31.21 | 32.7 | 24.66 | 11.97 | |||||
(EBITDA - Capex) / Interest Expense | 17.38 | 28.01 | 28.89 | 21.51 | 10.74 | |||||
Total Debt / EBITDA | 2.23 | 1.94 | 2.21 | 1.92 | 1.15 | |||||
Net Debt / EBITDA | 1.46 | 1.08 | 0.52 | 0.5 | -0.33 | |||||
Total Debt / (EBITDA - Capex) | 2.51 | 2.16 | 2.5 | 2.2 | 1.28 | |||||
Net Debt / (EBITDA - Capex) | 1.65 | 1.2 | 0.59 | 0.57 | -0.36 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 11.52 | -0.78 | 1.84 | 10.88 | 5.71 | |||||
Gross Profit, 1 Yr. Growth % | 11.32 | 1.33 | 2.09 | 10.18 | 4.78 | |||||
EBITDA, 1 Yr. Growth % | -0.89 | 12.66 | -21.18 | -0.77 | 1.1 | |||||
EBITA, 1 Yr. Growth % | -1.02 | 14.17 | -22.97 | -1.08 | -0.5 | |||||
EBIT, 1 Yr. Growth % | -2.1 | 14.73 | -24.23 | -2.13 | 1.86 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -17.56 | 56.72 | 1.78 | -68.24 | 17.41 | |||||
Net Income, 1 Yr. Growth % | -18.66 | 54.92 | 2.16 | -56.54 | 168.78 | |||||
Normalized Net Income, 1 Yr. Growth % | -4.13 | 11.25 | -23.78 | 8.39 | -6.35 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -18.7 | 56.47 | 2.4 | -56.45 | 3.26 | |||||
Accounts Receivable, 1 Yr. Growth % | 22.32 | -18.04 | -5.02 | -1.78 | 1.92 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 64.01 | -9.49 | -0.85 | -2.2 | -14.15 | |||||
Total Assets, 1 Yr. Growth % | 16.92 | -2.89 | 21.73 | 1.38 | -5.3 | |||||
Tangible Book Value, 1 Yr. Growth % | -255.54 | -43.97 | -336.43 | -14.58 | 253.21 | |||||
Common Equity, 1 Yr. Growth % | 6.64 | -3.35 | 30.75 | 3.43 | 7.39 | |||||
Cash From Operations, 1 Yr. Growth % | -18.75 | 105.78 | -13.5 | -9.26 | 12.13 | |||||
Capital Expenditures, 1 Yr. Growth % | -43.96 | -0.12 | -1.96 | 9.25 | -10.49 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 35.36 | 15.63 | 5.81 | -1.18 | -10.13 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 34.53 | 13.98 | 5.31 | -0.62 | -6.59 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.33 | 17.09 | 5.41 | 5.13 | 7.32 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 8.37 | 5.19 | 0.52 | 6.26 | 7.6 | |||||
Gross Profit, 2 Yr. CAGR % | 8.16 | 6.21 | 2.37 | 6.75 | 7.02 | |||||
EBITDA, 2 Yr. CAGR % | 2.97 | 3.33 | -6.97 | -11.88 | -3.85 | |||||
EBITA, 2 Yr. CAGR % | 8.88 | 9.39 | 1.49 | -5.81 | 3.22 | |||||
EBIT, 2 Yr. CAGR % | 5.23 | 5.98 | -2.2 | -9.67 | 0.88 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -8.72 | 13.67 | 26.3 | -43.14 | -27.36 | |||||
Net Income, 2 Yr. CAGR % | -8.97 | 12.25 | 25.8 | -33.37 | 8.07 | |||||
Normalized Net Income, 2 Yr. CAGR % | 4.17 | 3.7 | 0 | -3.65 | 4.12 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -8.88 | 12.79 | 26.58 | -33.22 | -24.97 | |||||
Accounts Receivable, 2 Yr. CAGR % | 14.1 | 0.13 | -11.77 | -3.41 | 0.05 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 40.8 | 21.84 | -5.27 | -1.53 | -8.37 | |||||
Total Assets, 2 Yr. CAGR % | 19.05 | 6.55 | 8.72 | 11.1 | -2.01 | |||||
Tangible Book Value, 2 Yr. CAGR % | 52.74 | -6.7 | 14.35 | 42.15 | 74.47 | |||||
Common Equity, 2 Yr. CAGR % | 9.84 | 1.52 | 12.41 | 16.29 | 5.39 | |||||
Cash From Operations, 2 Yr. CAGR % | -16.76 | 29.3 | 33.42 | -11.4 | 0.87 | |||||
Capital Expenditures, 2 Yr. CAGR % | -19.95 | -25.19 | -1.05 | 3.49 | 5.82 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 4.13 | 26.12 | 13.8 | 4.88 | -4.77 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 4.89 | 24.79 | 12.64 | 4.87 | -2.62 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.23 | 11.06 | 11.09 | 5.27 | 6.22 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 7.69 | 5.23 | 4.06 | 3.86 | 4.51 | |||||
Gross Profit, 3 Yr. CAGR % | 7.44 | 5.84 | 5.27 | 4.91 | 5.13 | |||||
EBITDA, 3 Yr. CAGR % | 1.45 | 6.11 | -2.98 | -4.98 | -3.91 | |||||
EBITA, 3 Yr. CAGR % | 5.13 | 10.61 | 0.28 | 0.59 | 1.93 | |||||
EBIT, 3 Yr. CAGR % | 2.77 | 8.3 | -2.17 | -2.18 | 0.38 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -2.43 | 9.3 | 9.56 | -20.28 | -11.99 | |||||
Net Income, 3 Yr. CAGR % | -3.03 | 8.68 | 8.78 | -11.73 | 6.06 | |||||
Normalized Net Income, 3 Yr. CAGR % | 3.04 | 6.47 | -6.07 | 2.72 | 7.57 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -2.94 | 9.12 | 9.21 | -11.3 | -9.75 | |||||
Accounts Receivable, 3 Yr. CAGR % | 9.1 | 2.18 | -1.62 | -8.56 | -1.67 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 30.91 | 21.52 | 13.75 | -4.26 | -5.93 | |||||
Total Assets, 3 Yr. CAGR % | 10.79 | 11.23 | 11.38 | 6.22 | 5.34 | |||||
Tangible Book Value, 3 Yr. CAGR % | 59.16 | 9.3 | 26.65 | 3.77 | 93.1 | |||||
Common Equity, 3 Yr. CAGR % | 5.24 | 5.26 | 10.45 | 9.34 | 13.25 | |||||
Cash From Operations, 3 Yr. CAGR % | -8.93 | 12.56 | 13.09 | 17.33 | -4.17 | |||||
Capital Expenditures, 3 Yr. CAGR % | -6.55 | -13.82 | -18.13 | 2.27 | -1.28 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 16.39 | 8.41 | 21.22 | 8.35 | -4.02 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 16.43 | 8.39 | 20.13 | 7.82 | -2.71 | |||||
Dividend Per Share, 3 Yr. CAGR % | 8.12 | 9.74 | 9.14 | 9.07 | 5.95 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.43 | 5.63 | 4.76 | 5.64 | 4.78 | |||||
Gross Profit, 5 Yr. CAGR % | 8.83 | 5.98 | 5.38 | 6.2 | 5.56 | |||||
EBITDA, 5 Yr. CAGR % | 3.06 | 4.18 | 0.12 | 0.26 | 0.67 | |||||
EBITA, 5 Yr. CAGR % | 4.71 | 7.03 | 2.26 | 2.42 | 3.53 | |||||
EBIT, 5 Yr. CAGR % | 3.29 | 5.69 | 0.75 | 0.72 | 2.59 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 0.55 | 11.57 | 8.18 | -15.84 | -2.51 | |||||
Net Income, 5 Yr. CAGR % | 0.25 | 10.92 | 7.61 | -10.64 | 8.5 | |||||
Normalized Net Income, 5 Yr. CAGR % | 1.8 | 5.4 | -1.27 | 0.16 | 3.79 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 0.29 | 11.19 | 7.94 | -10.34 | -1.33 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.2 | 3.59 | 0.22 | -0.09 | -0.95 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 21.52 | 18.38 | 15.02 | 11.71 | 4.33 | |||||
Total Assets, 5 Yr. CAGR % | 9.32 | 7.15 | 9.96 | 11.18 | 5.82 | |||||
Tangible Book Value, 5 Yr. CAGR % | -13.79 | -15.16 | 39.41 | 21.1 | 43.98 | |||||
Common Equity, 5 Yr. CAGR % | 9.54 | 5.02 | 8.05 | 9.54 | 8.4 | |||||
Cash From Operations, 5 Yr. CAGR % | -0.02 | 14.61 | 6.1 | 2.28 | 8.03 | |||||
Capital Expenditures, 5 Yr. CAGR % | 2.08 | 5.11 | -4.38 | -7.27 | -11.65 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.9 | 8.87 | 15.72 | 6.99 | 7.06 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 14.21 | 8.75 | 15.26 | 6.97 | 7.48 | |||||
Dividend Per Share, 5 Yr. CAGR % | 7.51 | 9.98 | 9.3 | 7.93 | 7.96 |